secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0001453687-24-000108
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve conversion of Series B Preferred at special meeting
------------------------------------------------------------------------

- Special meeting held Sep 20, 2024; 75.9% of outstanding shares represented.
- Proposal 1 passed: 12,514,261 FOR, 150,060 AGAINST, 1,650 abstentions (excluding 3,563,247 shares for Nasdaq compliance).
- Proposal 2 (adjournment if needed) approved: 16,076,183 FOR, 151,789 AGAINST, 1,246 abstentions.
- Approval allows issuance of common stock upon conversion of Series B Non-Voting Convertible Preferred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000108/0001453687-24-000108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000108/rnac-20240920.htm
  HTML page:      https://secwatch.observer/filing/0001453687-24-000108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer